| PERIOD ENDING | 31-Dec-07 | 30-Sep-07 | 30-Jun-07 | 31-Mar-07 | | Total Revenue | 505 | 666 | 779 | 617 | | Cost of Revenue | 439 | 467 | 562 | 492 | | | Gross Profit | 67 | 199 | 217 | 125 | | | Operating Expenses | | Research Development | 89 | 64 | 72 | 81 | | Selling General and Administrative | 790 | 732 | 742 | 851 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (812) | (596) | (597) | (807) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (82) | 306 | 1,281 | 281 | | Earnings Before Interest And Taxes | (895) | (290) | 684 | (526) | | Interest Expense | 435 | 427 | 363 | 336 | | Income Before Tax | (1,330) | (717) | 321 | (863) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,330) | (717) | 321 | (863) | | | Non-recurring Events | | Discontinued Operations |
-
| (1) | (20) | (37) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,330) | (718) | 301 | (899) | | Preferred Stock And Other Adjustments |
-
| (152) |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,330) | ($870) | $301 | ($899) |
|
0.67% Nasdaq 
Income Statement
